Relmada Therapeutics(RLMD)
$3.01-0.60 (-16.62%)
RLMD
Relmada Therapeutics earnings date
$3.01
At close:-0.60 (-16.62%)
Want to see RLMD full AI Analyst Report?
Relmada Therapeutics (RLMD) Earnings Dates, Call Summary & Reports
445 Followers
Earnings Data
- Estimated Report Date
- Mar 23, 2027
- Period Ending
- 2026 (Q4)
- Consensus EPS Forecast
- -0.13
- Last Year’s EPS
- -0.27
TBA (Not Confirmed)
Same Quarter Last Year
Relmada Therapeutics (RLMD) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced.
RLMD Q3 2026 Earnings Report
RLMD Upcoming Earnings
Relmada Therapeutics's next earnings date is estimated for March 23, 2027, based on past reporting schedules.
RLMD Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release | Slides | Play Transcript |
|---|---|---|---|---|---|---|---|
| Mar 23, 2027 | 2026 (Q4) | -0.13- | -0.27 | ― | ― | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.14-0.12 | -0.3 | 60.00% (+0.18) | |||
| Aug 06, 2026 | 2026 (Q2) | -0.20-0.11 | -0.3 | 63.33% (+0.19) | ― | ||
| May 12, 2026 | 2026 (Q1) | -0.20-0.22 | -0.58 | 62.07% (+0.36) | ― | ||
| Mar 19, 2026 | 2025 (Q4) | -0.15-0.27 | -0.62 | 56.45% (+0.35) | ― | ||
| Nov 13, 2025 | 2025 (Q3) | -0.42-0.30 | -0.72 | 58.33% (+0.42) | ― | ||
| Aug 07, 2025 | 2025 (Q2) | -0.46-0.30 | -0.59 | 49.15% (+0.29) | ― | ||
| May 12, 2025 | 2025 (Q1) | -0.48-0.58 | -0.72 | 19.44% (+0.14) | ― | ||
| Mar 27, 2025 | 2024 (Q4) | -0.67-0.62 | -0.84 | 26.19% (+0.22) | ― | ||
| Nov 07, 2024 | 2024 (Q3) | -0.68-0.72 | -0.73 | 1.37% (+0.01) | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous quarter.
Beat Missed
RLMD Earnings-Related Price Changes
| Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 12, 2026 | $4.16 | $4.21 | +1.20% |
| Aug 06, 2026 | $5.37 | $4.94 | -8.01% |
| May 12, 2026 | $7.45 | $7.49 | +0.54% |
| Mar 19, 2026 | $6.25 | $6.07 | -2.88% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after its recent earnings reports.
FAQ
When does Relmada Therapeutics (RLMD) report earnings?
Relmada Therapeutics (RLMD) is estimated to report earnings on Mar 23, 2027, TBA (Not Confirmed). The date is an estimate based on past reporting schedules and may change.
What is RLMD EPS forecast?
RLMD EPS forecast for the fiscal quarter 2026 (Q4) is -0.13.

